Klazien Matter-Walstra
Cost-effectiveness of nivolumab in the treatment of head and neck cancer.
Hirschmann A, Lupatsch JE, Schwenkglenks M, Panje CM, Matter-Walstra K, Espeli V, Dedes KJ, Siano M; Swiss Group of Clinical Cancer Research (SAKK).
Oral Oncol. 2018 Dec;87:104-110. doi: 10.1016/j.oraloncology.2018.10.032. Epub 2018 Oct 30.
Sa
21
Dez
2019
Newest Publication
Panje CM, Putora PM, Hundsberger T, Hottinger AF, Roelcke U, Pesce G, Herrmann E, Matter-Walstra K.
Swiss Med Wkly. 2019 Dec 2;149:w20153. doi: 10.4414/smw.2019.20153. eCollection 2019 Dec 2.